| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |